Janet Hardy

Janet Hardy, November 10, 2009 Janet W. Hardy is an American writer and sex educator, and founder of Greenery Press. She has also been published as ''Catherine A. Liszt'' and ''Lady Green''. She is the author or co-author of eleven books, and frequently collaborates with Dossie Easton.

She is genderqueer (and uses she/her pronouns), bisexual, and polyamorous. Provided by Wikipedia
Showing 1 - 5 results of 5 for search 'Janet Hardy', query time: 0.02s Refine Results
  1. 1
    Is there a role for hypnosis in palliative care?

    Is there a role for hypnosis in palliative care? by Petra Vayne-Bossert, Janet Hardy

    Published 2025-02-01
    Get full text
    Article
  2. 2
    ‘What price do you put on your health?’: Medical cannabis, financial toxicity and patient perspectives on medication access in advanced cancer

    ‘What price do you put on your health?’: Medical cannabis, financial toxicity and patient perspectives on medication access in advanced cancer by Rebecca E. Olson, Alexandra Smith, Phillip Good, Morgan Dudley, Taylan Gurgenci, Janet Hardy

    Published 2023-02-01
    Get full text
    Article
  3. 3
    Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer—a study protocol for a randomised controlled trial

    Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer—a study... by Taylan Gurgenci, Janet Hardy, Georgie Huggett, Karyn Foster, Anita Pelecanos, Ristan Greer, Jennifer Philip, Alison Haywood, Ruwani Mendis, Patsy Yates, Phillip Good

    Published 2024-05-01
    Get full text
    Article
  4. 4
    Correction: Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer—a study protocol for a randomised controlled trial

    Correction: Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with can... by Taylan Gurgenci, Janet Hardy, Georgie Huggett, Karyn Foster, Anita Pelecanos, Ristan Greer, Jennifer Philip, Alison Haywood, Ruwani Mendis, Patsy Yates, Phillip Good

    Published 2024-05-01
    Get full text
    Article
  5. 5
    The effects of OPRM1 118A>G on methadone response in pain management in advanced cancer at end of life

    The effects of OPRM1 118A>G on methadone response in pain management in advanced cancer at end of life by Larisa M. Haupt, Alison Haywood, Heidi G. Sutherland, Chieh Yu, Cassie L. Albury, Anushka Pharasi, Mathew Zunk, Rani George, Lyn R. Griffiths, Phillip Good, Janet Hardy

    Published 2024-02-01
    Get full text
    Article

Search Tools: